Evidence map›Paper›PMID 41011248›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Development and Evaluation of Liposomal

Xuebin Li, Chaoqun Yu, Gongyi Zheng, Yanghong Li, Weiguo Cao, Fan Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xuebin LiCollege of Traditional Chinese Medicine, Chongqing Medical University, Chongqing 400016, China.
Chaoqun YuResearch Center of Pharmaceutical Preparations and Nanomedicine, College of Pharmacy, Chongqing Medical University, Chongqing 400016, China.
Gongyi ZhengCollege of Traditional Chinese Medicine, Chongqing Medical University, Chongqing 400016, China.
Yanghong LiCollege of Traditional Chinese Medicine, Chongqing Medical University, Chongqing 400016, China.
Weiguo CaoCollege of Chinese Materia Medica, Chongqing University of Chinese Medicine, Chongqing 402760, China.
Fan WangCollege of Chinese Materia Medica, Chongqing University of Chinese Medicine, Chongqing 402760, China.

Funding

Chongging Municipal Science and Technology Bureau Chongqing Special Major Project for Technological Innovation and Application Development of Chongqing CSTB2024TIAD-STX0041Chongqing Health CommissionBayu Qihuang Scholars Support Project 2023-23-14Chongqing municipal talent plan "Lump sum project" of Chongqing Science and Technology Bureau cstc2024ycjh-bgzxm0111Natural Science Foundation of Chongqing Municipal Bureau of Science and Technology CSTB2024NSCQ-MSX1086Science and Technology Research Program of Chongqing Municipal Education Commission KJQN 202315137
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Celastrol-PROTACsPEGylated liposomesreduce toxicitytargeting efficiencytriple-negative breast cancer

Identifiers

PMID41011248
PMCPMC12472451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.